文献速递睡眠障碍心境障碍会诊联络精神医学

失眠障碍的全基因组分析

Genome-wide analysis of insomnia disorder.
PubMed 文献 · Mol Psychiatry · 2018-03-08

该研究对军人队列STARRS进行失眠障碍的全基因组关联研究,按祖先分组(EUR、AFR、LAT)分别开展logistic回归并跨研究、跨祖先meta分析。结果显示EUR组SNP遗传力显著(h2g=0.115,p=1.78×10-4),meta分析发现7号染色体q11.22位点全基因组显著(top SNP rs186736700,OR=0.607,p=4.88×10-9),EUR组9号染色体RFX3基因水平关联显著(p=7.61×10-7);失眠障碍遗传风险与重性抑郁障碍、2型糖尿病正相关,与晨型chronotype和主观幸福感负相关。

要点

  • EUR组失眠障碍SNP遗传力显著(h2g=0.115,p=1.78×10-4)。
  • 跨三祖先三队列meta分析发现Chr7 q11.22全基因组显著位点(rs186736700,OR=0.607,p=4.88×10-9)。
  • 失眠障碍遗传风险与重性抑郁障碍(rg=0.44,p=0.047)、2型糖尿病(rg=0.43,p=0.037)正相关。

核心结论

  • 失眠障碍存在显著SNP遗传力,并发现Chr7 q11.22全基因组显著位点及EUR组RFX3基因水平显著关联。
  • 失眠障碍遗传风险与重性抑郁障碍、2型糖尿病正相关,与晨型chronotype和主观幸福感负相关。
  • 失眠相关位点可能贡献于包括精神障碍和代谢疾病在内的一系列健康状况的遗传风险。

研究设计与样本

  • 在军人STARRS队列中按祖先分组(EUR、AFR、LAT)对每个组成研究分别进行logistic回归GWAS,含3,237例病例和14,414例对照。
  • 随后跨研究和跨祖先组进行meta分析,并计算SNP遗传力及与外部数据集的遗传相关性。

主要发现

  • EUR组终生失眠障碍SNP遗传力显著(h2g=0.115,p=1.78×10-4)。
  • 包含三个祖先组和三个研究队列的meta分析发现Chr7 q11.22全基因组显著位点(top SNP rs186736700,OR=0.607,p=4.88×10-9)。
  • EUR组Chr9 RFX3基因水平关联全基因组显著(p=7.61×10-7)。
  • UK Biobank中失眠/睡眠不足严重度的多基因风险与STARRS失眠障碍可能性显著正相关。
  • 失眠障碍遗传贡献与重性抑郁障碍(rg=0.44,se=0.22,p=0.047)、2型糖尿病(rg=0.43,se=0.20,p=0.037)正相关,与晨型chronotype(rg=-0.34,se=0.17,p=0.039)、主观幸福感(rg=-0.59,se=0.23,p=0.009)负相关。

关键数值与推荐

  • EUR组SNP遗传力h2g=0.115,p=1.78×10-4。
  • Chr7 q11.22 top SNP rs186736700,OR=0.607,p=4.88×10-9。
  • EUR组RFX3基因水平关联p=7.61×10-7。
  • 与重性抑郁障碍rg=0.44,se=0.22,p=0.047;与2型糖尿病rg=0.43,se=0.20,p=0.037。
  • 与晨型chronotype rg=-0.34,se=0.17,p=0.039;与主观幸福感rg=-0.59,se=0.23,p=0.009。

临床怎么用

  • 失眠障碍的遗传评估需考虑与重性抑郁障碍、2型糖尿病的共享遗传风险。
  • 失眠相关遗传位点可能为精神障碍和代谢疾病的跨诊断风险分层提供线索。
  • 临床关注失眠时,可留意其与晨型chronotype及主观幸福感的负向遗传关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Insomnia is a worldwide problem with substantial deleterious health effects. Twin studies have shown a heritable basis for various sleep-related traits, including insomnia, but robust genetic risk variants have just recently begun to be identified. We conducted genome-wide association studies (GWAS) of soldiers in the Army Study To Assess Risk and Resilience in Servicemembers (STARRS). GWAS were carried out separately for each ancestral group (EUR, AFR, LAT) using logistic regression for each of the STARRS component studies (including 3,237 cases and 14,414 controls), and then meta-analysis was conducted across studies and ancestral groups. Heritability (SNP-based) for lifetime insomnia disorder was significant (h2g = 0.115, p = 1.78 × 10-4 in EUR). A meta-analysis including three ancestral groups and three study cohorts revealed a genome-wide significant locus on Chr 7 (q11.22) (top SNP rs186736700, OR = 0.607, p = 4.88 × 10-9) and a genome-wide significant gene-based association (p = 7.61 × 10-7) in EUR for RFX3 on Chr 9. Polygenic risk for sleeplessness/insomnia severity in UK Biobank was significantly positively associated with likelihood of insomnia disorder in STARRS. Genetic contributions to insomnia disorder in STARRS were significantly positively correlated with major depressive disorder (rg = 0.44, se = 0.22, p = 0.047) and type 2 diabetes (rg = 0.43, se = 0.20, p = 0.037), and negatively with morningness chronotype (rg = -0.34, se = 0.17, p = 0.039) and subjective well being (rg = -0.59, se = 0.23, p = 0.009) in external datasets. Insomnia associated loci may contribute to the genetic risk underlying a range of health conditions including psychiatric disorders and metabolic disease.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Stein MB, McCarthy MJ, Chen CY, et al. Genome-wide analysis of insomnia disorder. Mol Psychiatry. 2018. PMID: 29520036. doi:10.1038/s41380-018-0033-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。